Stockreport

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation [TheStreet.com]

Virax Biolabs Group Limited - Ordinary Shares  (VRAX) 
PDF LONDON March 31, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that Virax Biolabs (UK) Limited, its wholly [Read more]